Identification and external validation of IgA nephropathy patients benefiting from immunosuppression therapy

BACKGROUND: Although IgA nephropathy (IgAN), an immune-mediated disease with heterogeneous clinical and pathological phenotypes, is the most common glomerulonephritis worldwide, it remains unclear which IgAN patients benefit from immunosuppression (IS) therapy. METHODS: Clinical and pathological dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tingyu, Xia, Eryu, Chen, Tiange, Zeng, Caihong, Liang, Shaoshan, Xu, Feng, Qin, Yong, Li, Xiang, Zhang, Yuan, Liang, Dandan, Xie, Guotong, Liu, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016365/
https://www.ncbi.nlm.nih.gov/pubmed/32062356
http://dx.doi.org/10.1016/j.ebiom.2020.102657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016365/
https://www.ncbi.nlm.nih.gov/pubmed/32062356
http://dx.doi.org/10.1016/j.ebiom.2020.102657

Ejemplares similares